Skip to main content
SpringerLink
Log in

Significance of examination of prostate-specific antigen and prostate-specific antigen density in patients with prostatic hyperplasia and prostate cancer

  • Published:
International Urology and Nephrology Aims and scope Submit manuscript

Abstract

Authors investigated PSA concentration and preoperative prostate volume in 113 histologically proved BPH and 31 prostatic cancer patients. PSA concentration was measured with the Hybritech kit, the prostate volume by ultrasound with the help of an ellipse and calculated by computer. There was no correlation between the age of patients and volume of the prostate, whereas a correlation was proved between marker concentration and prostate volume (p<0.0001). The difference obtained by the correlation of the prostate volume and the PSA concentration ratio between the BPH and 31 tumorous patients (PSA density) was highly significant (0.143 vs. 0.699, p<0.001). The use of PSAD further improves the diagnostic value of PSA.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Andriole, G. L., Teller, W. B., Coplen, D. E., Catalona, W. J.: PSA index (PSAI) as a predictor of prostate cancer (CaP) in men with persistent serum PSA elevation.J. Urol., 149, 387 (1993).

    Google Scholar 

  2. Benson, M. C., Whang, J. S., Olsson, G. A., McMakon, D. J., Conner, W. H.: The use of prostate specific antigen density to enhance the predictive value of intermediate levels of serum prostate specific antigen.J. Urol., 147, 817 (1992).

    PubMed  CAS  Google Scholar 

  3. Carter, H. B., Morell, C. H., Pearson, J. D., Brant, L. J., Plato, C. C., Metter, F. J., Chan, D. W., Fozard, J. L., Walsh, P. C.: Estimation of prostatic growth using serial prostate-specific antigen measurements in men with and without prostate disease.Cancer Res., 52, 3323 (1981).

    Google Scholar 

  4. Chu, T. M., Murphy, G. P.: What's new in tumor markers for prostatic cancer.Urology, 27, 487 (1986).

    Article  PubMed  CAS  Google Scholar 

  5. Collins, G. N., Lee, R. J., McKelvie, G. B., Rogers, A. C., Hehir, M.: Relationship between prostate specific antigen, prostate volume and age in the benign prostate,Br. J. Urol., 71, 455 (1993).

    Google Scholar 

  6. Densel, A., May, P.: Die Beeinflussung des PSA-Wertes durch benigne Prostataerkrankungen.Urology [B],31, 217 (1991).

    Google Scholar 

  7. Oesterling, J. E.: Prostate specific antigen: Critical assessment of most useful tumor marker for adenocarcinoma of prostate,J. Urol., 145, 907 (1991).

    PubMed  CAS  Google Scholar 

  8. Ramon, J., Billebaud, T., Astier, L., Kobelinsky, M., Meulemans, A., Dauge, M. C., Boccon-Gibod, L., Villers, A.: Prostate-specific antigen density: A means to enhance detection of prostate cancer,Eur. Urol., 25, 288 (1994).

    PubMed  CAS  Google Scholar 

  9. Semjonow, A., Hamm, M., Rathert, P.: Der Quotient aus Prostataspezifischem Antigen und Prostatavolumen. Verbesserte Unterscheidung zwischen benigner Prostatahyperplasie und lokal begrenztem Prostatakarzinom.Urologe [A],32, 250 (1993).

    CAS  Google Scholar 

  10. Walz, P. H., Schoppmann, T., Buscher, C., Ennen, J., Schriewer, H.: Influence of prostatic disease and prostatic manipulations on the concentration of prostate-specific antigen.Eur. Urol., 22, 20 (1982).

    Google Scholar 

  11. Wang, M. C., Valenzuela, L. A., Murphy, G. P., Chu, T. M.: Purification of a human prostatic aspectic antigen,Invest. Urol., 17, 159 (1979).

    PubMed  CAS  Google Scholar 

  12. Wolff, J. M., Scholz, A., Boeckmann, W., Jakse, G.: Differentiation of benign prostatic hyperplasia and prostate cancer employing prostate-specific antigen density.Eur. Urol., 25, 295 (1994).

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Urology, National Institute of Rheumatology and Physiotherapy, Budapest, Hungary

    I. Romics

  2. Department of Urology, Semmelweis University Medical School, Budapest, Hungary

    D. Frang

  3. Department “C” of Internal Medicine, National Institute of Oncolology, Budapest, Hungary

    I. Bodrogi

Authors
  1. I. Romics
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. D. Frang
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. I. Bodrogi
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Romics, I., Frang, D. & Bodrogi, I. Significance of examination of prostate-specific antigen and prostate-specific antigen density in patients with prostatic hyperplasia and prostate cancer. International Urology and Nephrology 29, 449–455 (1997). https://doi.org/10.1007/BF02551112

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02551112

Keywords

Search

Navigation